Month: January 2019

Global Probiotics Council – Young Investigator Grant for Probiotics Research

1/31/2019

The Global Probiotics Council (GPC), a committee established in 2004 by DANONE NUTRICIA RESEARCH and YAKULT HONSHA CO., LTD., has announced the twelfth annual Young Investigator Grant for Probiotics Research…

DOD – Joint Warfighter Medical Research Program (JWMRP)

1/18/2019

The FY19 Joint Warfighter Medical Research Program (JWMRP) Request for Information (RFI) was released on January 3.  This program is specifically designed for previous DoD awardees and intended to fund…

DOD – CDMRP Releases FY 2019 Peer Reviewed Medical Research Program Solicitations

1/18/2019

Purpose The Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) released its fiscal year (FY) 2019 Peer Reviewed Medical Research Program (PRMRP) solicitations. In FY 2019, Congress allocated…

NIH – Exploratory/Developmental Bioengineering Research Grants(EBRG) (R21, two FOAs)

1/17/2019

Exploratory/Developmental Bioengineering Research Grants(EBRG) (R21 Clinical Trial Not Allowed) The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications…

NIH – Drug Discovery For Nervous System Disorders (R01, R21 Clinical Trial Not Allowed)

1/17/2019

The following description was taken from the R01 version of this FOA. Significant advances in neuroscience, genetics, and basic behavioral science, together with technological developments, have provided a rich knowledge…

NIH – The Human Biomolecular Atlas Program (HuBMAP): Rapid Implementation of Technologies that Will Accelerate Development of a Framework for Mapping the Human Body at High Resolution (UH3 Clinical Trial Not Allowed)

1/17/2019

The vision for the Human BioMolecular Atlas Program (HuBMAP) is to catalyze development of a framework for mapping of the human body at high resolution to transform our understanding of…

NIH/NCI – Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)

1/17/2019

This Funding Opportunity Announcement (FOA) is associated with the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act of 2018 which authorizes the National Cancer Institute (NCI) to fund research to improve…

NIH/NCI – Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (multiple RFAs)

1/17/2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) (RFA-CA-19-023) Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)…

NIH/NCI – Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

1/17/2019

This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for…

NIH/NCI – Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

1/17/2019

This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on early-stage development of highly innovative technologies that improve the quality of the samples used for cancer…